Expression of C II TA gene in five human malignant hematological cell lines and its significance

You Yong , Zou Ping , Guo Rong

Current Medical Science ›› 2004, Vol. 24 ›› Issue (8) : 338 -341.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (8) : 338 -341. DOI: 10.1007/BF02861862
Article

Expression of C II TA gene in five human malignant hematological cell lines and its significance

Author information +
History +
PDF

Abstract

The role of MHC class II transactivator (C II TA) in constitutive or IFN-γ inducible expression of HLA molecules in human malignant hematological cell lines was investigated. The expression of HLA molecules and C II TA protein was detected by Western blot, immunohistochemistry and flow cytometry. The expression of C II TA gene was determined by RT-PCR. The capability of peripheral blood T cell reaction stimulated by tumor cells was monitored by mixed lymphocyte reaction. It was found that the HLA II-positive tumor cells expressed the C II TA quite well, and the expression of HLA I + II was increased in the tumor cells with constitutive or inducible expression of C II TA after induced by IFN-γ. The tumor cells which did not express C II TA after induced by IFN-γ were not response to the expression of HLA II promoted by IFN-γ. It suggests a correlation between the inability of some malignant hematological cell lines in response to IFN-γ for HLA expression and the deficiency in the inducible expression of C II TA, indicating C II TA might take part in the regulation of HLA I+II expression in the tumor cells, which might play an important role in tumor immunologic escape.

Keywords

MHC class II transactivator / antigen, HLA / IFN-γ / tumor cells

Cite this article

Download citation ▾
You Yong, Zou Ping, Guo Rong. Expression of C II TA gene in five human malignant hematological cell lines and its significance. Current Medical Science, 2004, 24(8): 338-341 DOI:10.1007/BF02861862

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AichunL, MasuhiroT, KenT, et al. . Regulation of the expression of MHC class I and II by class II transactivator (C II TA) in hematopoietic cells. Hematol Oncol, 1999, 17149-149

[2]

GarridoF, CabreraT, ConchaA, et al. . Natural history of HLA expression during tumor development. Immunol Today, 1993, 41491-491

[3]

HollingT M, van Der StoepN, QuintenE, et al. . Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J Immunol, 2002, 168(2): 763-763

[4]

WaldburgerJ M, SuterT, FontanaA, et al. . Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med, 2001, 194(4): 393-393

[5]

MartenA, ZiskeC, SchottkerB, et al. . Transfection of dendritic cells (DCs) with the C II TA gene: increase in immunostimulatory activity of DCs. Cancer Gene Ther, 2001, 8(3): 211-211

AI Summary AI Mindmap
PDF

86

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/